[Serum levels of IAP, CEA and CA19-9 in patients with urological malignancies]. 1988

T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku

UI MeSH Term Description Entries
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D014571 Urologic Neoplasms Tumors or cancer of the URINARY TRACT in either the male or the female. Cancer of Urinary Tract,Urinary Tract Cancer,Urologic Cancer,Cancer of the Urinary Tract,Neoplasms, Urologic,Urinary Tract Neoplasms,Urological Cancer,Urological Neoplasms,Cancer, Urinary Tract,Cancer, Urologic,Cancer, Urological,Cancers, Urinary Tract,Cancers, Urologic,Cancers, Urological,Neoplasm, Urinary Tract,Neoplasm, Urologic,Neoplasm, Urological,Neoplasms, Urinary Tract,Neoplasms, Urological,Tract Neoplasm, Urinary,Tract Neoplasms, Urinary,Urinary Tract Cancers,Urinary Tract Neoplasm,Urologic Cancers,Urologic Neoplasm,Urological Cancers,Urological Neoplasm
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens

Related Publications

T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
March 1996, Minerva chirurgica,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
December 2000, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
January 1997, Oncology reports,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
January 1996, The American journal of gastroenterology,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
August 2022, Molecular and clinical oncology,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
December 2015, Annals of translational medicine,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
June 2001, World journal of gastroenterology,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
January 1999, The Turkish journal of pediatrics,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
March 2018, Clinical laboratory,
T Iizumi, and H Amemiya, and R Hata, and S Kaneko, and H Muramatsu, and T Kariba, and A Toyoshima, and T Yazaki, and M Waku
June 2004, Cancer research and treatment,
Copied contents to your clipboard!